4.7 Review

MicroRNAs as biomarkers of disease onset

期刊

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 401, 期 7, 页码 2051-2061

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-011-5001-8

关键词

MicroRNA; Biomarkers; Cancer; Heart diseases

资金

  1. Polish Ministry of Science and Higher Education
  2. Adamed Ltd.
  3. Wellcome Trust
  4. Ministry of Science and Higher Education
  5. European Union [POIG.02.01.00-12-064/08, 02.02.00-00-014/08, 01.0102-00-109/09, 01.01.02-00-069/09]
  6. European Commission
  7. [DWM/N148/INCA/08]
  8. [311/N-COST/2008]

向作者/读者索取更多资源

MicroRNAs (miRNAs) are small, noncoding RNA molecules with the ability to posttranscriptionally regulate gene expression via targeting the 3' untranslated region of messenger RNAs. miRNAs are critical for normal cellular functions such as the regulation of the cell cycle, differentiation, and apoptosis, and they target genes during embryonal and postnatal development, whereas their expression is unbalanced in various pathological states. Importantly, miRNAs are abundantly present in body fluids (e. g., blood), which are routinely examined in patients. These molecules circulate in free and exosome encapsulated forms, and can be efficiently detected and amplified by means of molecular biology tools such as real-time PCR. Together with relative stability, specificity, and reproducibility, they are seen as good candidates for early recognition of the onset of disease. Thus, miRNAs might be considered as biomarkers for many pathological states.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据